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Abstract 
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Abstract: Obesity and glioblastoma multiforme (GB) are two unmet medical needs where effective 
therapies are lacking. Carnitine palmitoyl transferase 1 (CPT1), an enzyme catalyzing the rate-lim-
iting step in fatty acid oxidation (FAO), is a viable target for both diseases. C75, a fatty acid synthase 
(FAS) inhibitor, forms an adduct with coenzyme A (CoA) to form C75-CoA, which is a strong com-
petitive inhibitor to CPT1 that is selective in its target. However, it is polar and charged, having low 
cell membrane permeability, and therefore needing a delivery system for intracellular transport. 
(±)-C75-CoA and its enantio-separated forms (+)- and (−)-C75-CoA were used to form poly-ion com-
plex (PIC) micelles with the cationic block co-polymer PEG-PAsp(DET). The drug and polymer 
were mixed in a 1:1 anion/cation ratio to give 50–70 nm micelles with a unimodal size profile and 
narrow polydispersity. Size was maintained upon introduction of physiological saline. Micellar (±)-, 
(+)-, and (−)-C75-CoA were all significantly more cytotoxic compared to the respective free drugs in 
U87MG. We examined whether C75-CoA inhibits FAO by measuring ATP concentrations in 
U87MG and GT1-7. ATP generation was found to be hampered after adding C75-CoA in both cell 
types, with micelle-treated cells producing significantly lower ATP than those treated with free 
drug, suggesting that the effective intracellular delivery of C75-CoA leads to a more pronounced 
FAO inhibition. A fluorescent CoA derivative, Fluor-CoA, also yielded monodisperse micelles sim-
ilar to C75-CoA. Micellar internalization was significantly greater than that of the free dye. Uptake 
of both increased with time, with this effect is more pronounced in U87MG than GT1-7. The %Fluor-
CoA+ cells were also expressively higher for the micelle across cell lines. From this data, it can be 
convincingly concluded that neuronal and glioma cellular uptake of micelles is superior to that of 
the free dye, validating the need for cellular delivery systems for anionic, CoA-type molecules. The 
micellar form neutralized the negative charge of the cargo, promoting transport into the cell. These 
outcomes strongly support the effectiveness of using a PIC micelle-type system to deliver anionic 
small molecules into glioma cells and neurons meant to inhibit enzymes such as CPT1, for future 
applications in diseases like obesity and cancer. 
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